Cargando…

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews

Aim: Evidence from overlapping systematic reviews (SRs) and meta-analyses (MAs) has yielded conflicting results on the treatment of irritable bowel syndrome (IBS) with fecal microbiota transplantation (FMT). To thoroughly gather, assess, and synthesize evidence on FMT for IBS, we carried out the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Di, Tang, Yan, Bai, Xiangyu, Li, Da, Zhou, Mengxue, Yu, Chunmei, Wu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616237/ https://www.ncbi.nlm.nih.gov/pubmed/37915416 http://dx.doi.org/10.3389/fphar.2023.1264779

Ejemplares similares

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
por: Abdelghafar, Yomna Ali, et al.
Publicado: (2022)

An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
por: Jun, Hyejin, et al.
Publicado: (2022)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Li, Bing, et al.
Publicado: (2020)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Hui-jun, et al.
Publicado: (2022)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome
por: Goll, Rasmus, et al.
Publicado: (2020)

Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
por: Rodrigues, Tânia, et al.
Publicado: (2023)

Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
por: Samuthpongtorn, Chatpol, et al.
Publicado: (2022)

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2023)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan
por: Hamazaki, Motonobu, et al.
Publicado: (2022)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
por: Tkach, Sergii, et al.
Publicado: (2022)

Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome
por: Ling, Xiwen, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea
por: Huang, Hong-Li, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jamshidi, Parnian, et al.
Publicado: (2023)

Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Wang, Mancai, et al.
Publicado: (2023)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease
por: Li, Qianqian, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
por: Chen, Liang, et al.
Publicado: (2022)

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
por: Yang, Fang, et al.
Publicado: (2021)

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia
por: Wang, Congzhen, et al.
Publicado: (2021)

Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study
por: Cui, Jiaqu, et al.
Publicado: (2021)

The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
por: Lin, Hao, et al.
Publicado: (2021)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7jn1otmrc3o3j5fenc4nhj7db